While 30%–70% of RSV-infected infants develop bronchiolitis, 2% require hospitalization. It is not clear why disease severity differs among healthy, full-term infants; however, virus titers, inflammation, and Th2 bias are proposed explanations. While TLR4 is associated with these disease phenotypes, the role of this receptor in respiratory syncytial virus (RSV) pathogenesis is controversial. Here, we evaluated the interaction between TLR4 and environmental factors in RSV disease and defined the immune mediators associated with severe illness. Two independent populations of infants with RSV bronchiolitis revealed that the severity of RSV infection is determined by the
Mauricio T. Caballero, M. Elina Serra, Patricio L. Acosta, Jacqui Marzec, Luz Gibbons, Maximiliano Salim, Andrea Rodriguez, Andrea Reynaldi, Alejandro Garcia, Daniela Bado, Ursula J. Buchholz, Diego R. Hijano, Silvina Coviello, Dawn Newcomb, Miguel Bellabarba, Fausto M. Ferolla, Romina Libster, Ada Berenstein, Susana Siniawaski, Valeria Blumetti, Marcela Echavarria, Leonardo Pinto, Andrea Lawrence, M. Fabiana Ossorio, Arnoldo Grosman, Cecilia G. Mateu, Carola Bayle, Alejandra Dericco, Mariana Pellegrini, Ignacio Igarza, Horacio A. Repetto, Luciano Alva Grimaldi, Prathyusha Gudapati, Norberto R. Polack, Fernando Althabe, Min Shi, Fernando Ferrero, Eduardo Bergel, Renato T. Stein, R. Stokes Peebles, Mark Boothby, Steven R. Kleeberger, Fernando P. Polack